Joseph B. Leader
Geisinger Medical Center(US)Tempus Labs (United States)(US)
Publications by Year
Research Areas
Genomics and Rare Diseases, Genetic Associations and Epidemiology, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease(2017)850 cited
- → Exome sequencing and characterization of 49,960 individuals in the UK Biobank(2020)622 cited
- → Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study(2016)593 cited
- → Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease(2016)500 cited
- → Genetic identification of familial hypercholesterolemia within a single U.S. health care system(2016)426 cited
- → Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls(2019)335 cited
- → Prediction of mortality from 12-lead electrocardiogram voltage data using a deep neural network(2020)292 cited
- → Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead ECG and Help Identify Those at Risk of Atrial Fibrillation–Related Stroke(2021)284 cited
- → Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?(2019)283 cited
- → Exome Sequencing–Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants(2018)210 cited